Literature DB >> 8846197

Role of histamine in a rat model of colitis.

C M Gelbmann1, K E Barrett.   

Abstract

We examined the possible involvement of mast cells in a rat model of colitis, by monitoring levels of histamine at various times after inducing inflammation with intrarectal trinitrobenzene sulfonic acid in 50% ethanol. The ability of a histamine H1 antagonist, diphenhydramine, to modify colitis was also assessed. As expected, trinitrobenzene sulfonic acid in 50% ethanol induced a sustained colitis. Myeloperoxidase levels in macroscopically damaged tissue peaked at one week, and declined thereafter. In contrast, tissue histamine levels were normal at one week, then increased in damaged tissue to approximately four times normal levels at four weeks. Indices of inflammation were markedly suppressed at one week by diphenhydramine, while tissue histamine levels were unaffected. Chronic colitis in rats is thus apparently accompanied by a local mast cell hyperplasia or influx. Moreover, antagonism of a major mast cell mediator, histamine, significantly reduces the severity of inflammation in this model.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8846197     DOI: 10.1007/bf01797866

Source DB:  PubMed          Journal:  Inflamm Res        ISSN: 1023-3830            Impact factor:   4.575


  33 in total

1.  The presence of histamine in tissue mast cells.

Authors:  J F RILEY; G B WEST
Journal:  J Physiol       Date:  1953-06-29       Impact factor: 5.182

2.  Enhancement of human intestinal mast cell mediator release in active ulcerative colitis.

Authors:  C C Fox; A J Lazenby; W C Moore; J H Yardley; T M Bayless; L M Lichtenstein
Journal:  Gastroenterology       Date:  1990-07       Impact factor: 22.682

Review 3.  Immunomodulation by histamine.

Authors:  L Stanciu
Journal:  Ann Biol Clin (Paris)       Date:  1990       Impact factor: 0.459

4.  Mast cells in ulcerative colitis. Quantitative and ultrastructural studies.

Authors:  M Balázs; G Illyés; G Vadász
Journal:  Virchows Arch B Cell Pathol Incl Mol Pathol       Date:  1989

Review 5.  Inflammation--histamine and 5-hydroxytryptamine.

Authors:  D A Owen
Journal:  Br Med Bull       Date:  1987-04       Impact factor: 4.291

6.  Repeated antigen challenge in rats induces a mucosal mast cell hyperplasia.

Authors:  J S Marshall
Journal:  Gastroenterology       Date:  1993-08       Impact factor: 22.682

7.  Ultrastructural evidence for piecemeal and anaphylactic degranulation of human gut mucosal mast cells in vivo.

Authors:  A M Dvorak; R S McLeod; A Onderdonk; R A Monahan-Earley; J B Cullen; D A Antonioli; E Morgan; J E Blair; P Estrella; R L Cisneros
Journal:  Int Arch Allergy Immunol       Date:  1992       Impact factor: 2.749

8.  Immunolocalization of cytokines in the nasal mucosa of normal and perennial rhinitic subjects. The mast cell as a source of IL-4, IL-5, and IL-6 in human allergic mucosal inflammation.

Authors:  P Bradding; I H Feather; S Wilson; P G Bardin; C H Heusser; S T Holgate; P H Howarth
Journal:  J Immunol       Date:  1993-10-01       Impact factor: 5.422

Review 9.  Endothelial adhesion molecules and their role in inflammation.

Authors:  C W Smith
Journal:  Can J Physiol Pharmacol       Date:  1993-01       Impact factor: 2.273

10.  Kinetics of histamine released from rectal mucosa.

Authors:  M Raithel; A M Hörauf; M Matek; H W Baenkler
Journal:  Agents Actions       Date:  1989-11
View more
  2 in total

Review 1.  Mechanisms for amplified mediator release from colonic mast cells: implications for intestinal inflammatory diseases.

Authors:  Kim E Barrett
Journal:  World J Gastroenterol       Date:  2004-03-01       Impact factor: 5.742

2.  Relationship between mast cells and the colitis with relapse induced by trinitrobenzesulphonic acid in Wistar rats.

Authors:  Ana Carolina Luchini; Déborah Mara Costa de Oliveira; Cláudia Helena Pellizzon; Luiz Claudio Di Stasi; José Carlos Gomes
Journal:  Mediators Inflamm       Date:  2009-05-11       Impact factor: 4.711

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.